Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and Taxanes

NCT03412955 is registered in ClinicalTrials.gov with Tan Tock Seng Hospital as lead sponsor.

NCT NCT03412955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03412955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and Taxanes
Lead sponsor
Tan Tock Seng Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
March 8, 2017
Completion date
April 30, 2020
Enrollment
14 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer